DSC test results of recycled asphalt samples. by Ying Fang (147352)

Local sensitivity analysis of total thrombin, free, and bound thrombin in the clot. by Jason Chen (15937)

The effect of BRA dosage on the <i>J</i>_<i>nr</i> value of aged asphalt. by Ying Fang (147352)

CT utilization rates for each combination of sex, age (in years), SES SVI vulnerability quartile, and BMI. by Mina Dawod (18933969)

MR utilization rates for each combination of sex, age (in years), SES SVI vulnerability quartile, and BMI. by Mina Dawod (18933969)

Number of patients (in millions) in each BMI cohort included in the study population (Total), stratified by age, sex, and socioeconomic status (SES) vulnerability quartile. by Mina Dawod (18933969)

Flowchart of the study sample selection process. by Chun-Chieh Chao (2681722)

Plasma protein levels and thrombin binding sites distribution of the subsets of top and bottom 2% of fibrin concentration of 10,000 simulations. by Jason Chen (15937)

Relative importance (%IncMSE) of explanatory factors in oxidation and antioxidant indexes responses to elevated O₃. by Yi Zhao (14034)

Sociodemographic characteristics and clinical history of participants. by Raphäel Rakotozandrindrainy (18389756)

Experimental setup of the chemotaxis assay. by Yixuan Chen (47490)

Data dictionary used to include the variables in the analysis. by Raphäel Rakotozandrindrainy (18389756)

Estimates of the prevalence of schistosome infection with respective 95% confidence intervals. by Raphäel Rakotozandrindrainy (18389756)

Flowchart of participants’ recruitment and urine sampling. by Raphäel Rakotozandrindrainy (18389756)

Diet composition and nutritional values. by Taynara Aparecida Vieira (16401726)

“…The HSF group exhibited obesity (HSF 8.77 ± 2.64 <i><i>vs</i></i> C 3.09 ± 1.02, <i>p = </i>0.007), dyslipidemia (HSF 94.4 ± 19.1 <i><i>vs</i></i> C 26.7 ± 5.2, <i><i>p < </i></i>0.001), hypertension (HSF 141 ± 8 <i><i>vs</i></i> C 120 ± 4, <i>p = </i>0.001), insulin resistance (HSF 6.91 ± 1.38 <i><i>vs</i></i> C 2.47 ± 1.01, <i><i>p < </i></i>0.001), cardiac remodeling and dysfunction, cardiac inflammation, decreased metalloproteinase-2 (MMP-2) (HSF 0.43 ± 0.09 <i><i>vs</i></i> C 0.71 ± 0.07, <i>p = </i>0.009) and increased type III collagen (HSF 1.32 ± 0.27 <i><i>vs</i></i> C 1.00 ± 0.18, <i>p = </i>0.038). …”

Nutritional and metabolic analysis. by Taynara Aparecida Vieira (16401726)

“…The HSF group exhibited obesity (HSF 8.77 ± 2.64 <i><i>vs</i></i> C 3.09 ± 1.02, <i>p = </i>0.007), dyslipidemia (HSF 94.4 ± 19.1 <i><i>vs</i></i> C 26.7 ± 5.2, <i><i>p < </i></i>0.001), hypertension (HSF 141 ± 8 <i><i>vs</i></i> C 120 ± 4, <i>p = </i>0.001), insulin resistance (HSF 6.91 ± 1.38 <i><i>vs</i></i> C 2.47 ± 1.01, <i><i>p < </i></i>0.001), cardiac remodeling and dysfunction, cardiac inflammation, decreased metalloproteinase-2 (MMP-2) (HSF 0.43 ± 0.09 <i><i>vs</i></i> C 0.71 ± 0.07, <i>p = </i>0.009) and increased type III collagen (HSF 1.32 ± 0.27 <i><i>vs</i></i> C 1.00 ± 0.18, <i>p = </i>0.038). …”

Cardiovascular parameters. by Taynara Aparecida Vieira (16401726)

“…The HSF group exhibited obesity (HSF 8.77 ± 2.64 <i><i>vs</i></i> C 3.09 ± 1.02, <i>p = </i>0.007), dyslipidemia (HSF 94.4 ± 19.1 <i><i>vs</i></i> C 26.7 ± 5.2, <i><i>p < </i></i>0.001), hypertension (HSF 141 ± 8 <i><i>vs</i></i> C 120 ± 4, <i>p = </i>0.001), insulin resistance (HSF 6.91 ± 1.38 <i><i>vs</i></i> C 2.47 ± 1.01, <i><i>p < </i></i>0.001), cardiac remodeling and dysfunction, cardiac inflammation, decreased metalloproteinase-2 (MMP-2) (HSF 0.43 ± 0.09 <i><i>vs</i></i> C 0.71 ± 0.07, <i>p = </i>0.009) and increased type III collagen (HSF 1.32 ± 0.27 <i><i>vs</i></i> C 1.00 ± 0.18, <i>p = </i>0.038). …”

Meta-analysis of the effects of elevated O₃ on POD activity of herbaceous plants. by Yi Zhao (14034)

Theory of change enhanced by integrating schistosomiasis treatment for pregnant women into public health programs. by Raphäel Rakotozandrindrainy (18389756)

Ultra-performance liquid chromatography–electrospray ionization–mass spectrometry analysis of Moutan Cortex extract. by Jin-Hwa Kim (101817)